Compound Detail
CHEMBL1382
TOLTERODINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1382 |
| Name | TOLTERODINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | OOGJQPCLVADCPB-HXUWFJFHSA-N |
| Therapeutic | ✓ Yes |
18
Targets
29
Activities
3
Assay Types
16
PK Parameters
20
Publications
13
Known Names
8
Indications
Molecular Properties
325.5
MW (Da)
5.34
ALogP
2
HBA
1
HBD
23.5
PSA (Ų)
0.74
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1998 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Polyuria Urinary Incontinence Low Back Pain Pain Pelvic Organ Prolapse Urinary Bladder, Overactive Kidney Calculi Neuralgia
ATC Classification
G04BD07
tolterodine
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
Ki 16 meas. best 8.85
IC50 11 meas. best 8.2
Kd 2 meas. best 7.8
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 163.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 1190.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 44.0 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.037 | - | - |
| Fu | 0.012 | - | - |
| Fu | 0.037 | - | Homo sapiens |
| Fu | 0.037 | - | Homo sapiens |
| Fu | 0.037 | - | Homo sapiens |
| Fu | 0.037 | - | Homo sapiens |
| MRT | 2.98 | hr | Homo sapiens |
| T1/2 | 2.4 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine